Vladislav A. Mileyko
Director, OncoAtlas LLC; Deputy Head of the Applied Genomic Technologies Laboratory, Laboratory for Applied Genomic Technologies, Institute for personalized oncology, I.M. Sechenov First Moscow State Medical University, ORCID: https://orcid.org/0000-0002-0272-1747
Статьи автора:
PATHWAY DIRECTED MECHANISMS OF ANTI-EGFR RESISTANCE IN COLORECTAL CANCER (REVIEW)
Background: Targeting the epidermal growth factor receptor (EGFR) with cetuximab or panitumumab (anti-EGFR MAb) has been historically reserved ...
